Cardiac complications in patients with severe COVID-19 pneumonia
https://doi.org/10.33667/2078-5631-2021-5-14-17
Abstract
This article is devoted to the analysis of the most frequent cardiac complications in patients with severe community-acquired pneumonia caused by COVID-19 viral infection. The study found that cardiac complications developed in 25% of patients with COVID-19 pneumonia. The most common complication was supraventricular rhythm disturbances. Atrial fibrillation and flutter proceeded with pronounced hemodynamic changes. Myocardial injury, given the increase in cardiospecific troponin T, could be suspected in 38% of patients. Differential diagnosis between ACS and myocarditis caused the greatest difficulties.
About the Authors
N. А. Yaroshchuk
GAUZ SO ‘Sverdlovsk Regional Clinical Neuropsychiatric hospital for war veterans’, Yekaterinburg
Russian Federation
Russian Federation
MD, PhD, Head of the Department of Functional and Ultrasound
Diagnostics
V. V. Kochmasheva
FGBOU ‘Ural State Medical University”, GAUZ SO “Sverdlovsk Regional Clinical Hospital No. 1’, Yekaterinburg
Russian Federation
Russian Federation
MD, Professor at the Department, Head of the Department of
Functional Diagnostics
A. V. Vakhrameev
GAUZ SO ‘Sverdlovsk Regional Clinical Neuropsychiatric hospital for war veterans’, Yekaterinburg
Russian Federation
Russian Federation
cardiologist
References
1. Akhmerov A., Marbán Е. COVID-19 and the heart. Circulation research. 2020;126(10):1443–1455.
2. Rath D., Petersen- Uribe Á., Avdiu A., Witzel K., Jaeger P., Zdanyte M., Gawaz M. P. Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection. Clinical Research in Cardiology. 2020; 1–9.
3. Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine. 2020;46(5):846–848.
4. Alekhin M. N., Ivanov S. I., Stepanova A. I. Clinical value of echocardiography in patients with COVID-19: a systematic review. Medicalalphabet. 2020;(32):8–13. https://doi.org/10.33667/2078-5631-2020-32-8-13
5. Bansal M. Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(3):247–250.
6. Liu P. P., Blet A., Smyth D., Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142:68–78 https://doi.org/10.1161/CIRCULATIONAHA.120.047549
7. Long B., Brady W. J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. The American journal of emergency medicine. 2020; 38,(7):1504–1507 https://doi.org/10.1016/j.ajem.2020.04.048
8. Basso C. et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study //European heart journal. — 2020. — Т. 41. — № 39. —С. 3827–3835.
9. Nishiga M., Wang D. W., Han Y., Lewis D. B., W, J. C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology.2020;17(9):543–558.
10. Januzzi J. L. Troponin and BNP use in COVID-19. Cardiology Magazine. 2020;18.
11. Lippi G., Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clinical Chemistry and Laboratory Medicine. 2020;58(7):1131–1134.
12. Sandoval Y., Januzzi Jr J. L., Jaffe A. S. Cardiac troponin for the diagnosis and risk-stratification of myocardial injury in COVID-19: JACC review topic of the week. Journal of the American College of Сardiology. 2020;76(10.8):1244–1258.
13. Guo T. Fan Y., Chen M., Wu X., Zhang L., He T., Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology. 2020; 5(7):811–818.
14. Haseeb S., Gul E. E., Çinier G., Bazoukis G., AlvarezGarcia J., Garcia- Zamora S., Baranchuk A. Value of electrocardiography in coronavirus disease 2019 (COVID-19). Journal of Electrocardiology. 2020;62:39–45.
15. Kochi A. N., Tagliari, A.P., Forleo G. B., Fassini G. M., Tondo C.l. Cardiac and arrhythmic complications in patients with COVID-19. Journal of Cardiovascular Electrophysiology. 2020;31(5):1003–1008.
16. Lazzerini P. E., Boutjdir M., Capecchi P. L. COVID-19, arrhythmic risk and inflammation: mind the gap! Circulation. 2020;142:7–9.
17. Bennett C. E., Anavekar N. S., Gulati R., Singh M., Kane G. C., Sandoval Y., Aske J. W. ST-segment elevation, myocardial injury, and suspected or confirmed COVID-19 patients: diagnostic and treatment uncertainties. Mayo Clinic Proceedings. Elsevier. 2020; 95(6):1107–1111.
18. Chen Q. Xu L., Dai Y., Ling Y., Mao J., Qian J., Ge J. Cardiovascular manifestations in severe and critical patients with COVID-19. Clinical cardiology. 2020;43(7):796–802.
19. Ni W., Yang X., Liu J., Bao J., Li R., Xu Y., Gao Z. Acute myocardial injury at hospital admission is associated with all-cause mortality in COVID-19. Journal of the American College of Cardiology. 2020;76(1):124–125.
20. Wang, Dawei, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
21. Mitrani R. D., Dabas N., Goldberger J. J. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors.Heart rhythm. 2020;17(11):1984–1990.
22. Bu J., Chen M., Cheng X., Dong Y., Fang W., Ge J. Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19. Nan Fang Yi Ke Da Xue Xue Bao. 2020;147–151.
23. Mahmud E., Dauerman H. L., Welt F. G., Messenger J. C., Rao S. V., Grines C., Rokos I. C. Management of acute myocardial infarction during the COVID-19 pandemic. Journal of the American College of Cardiology. 2020;76(11):1375–1384.
24. Grinevich V. B., Gubonina I. V., Doshchitsin V. L., Kotovskaya Yu. V., Kravchuk Yu. A., Ped ‘V. I., Tkacheva O. N. Features of the management of comorbid patients during the novel coronavirus pandemic infections (COVID-19). National Consensus 2020. Cardiovascular Therapy and Prevention. 2020;19(4): https://doi.org/10.15829/1728-8800-2020-2630.
25. Shlyakhto E. V., Konradi A. O., Arutyunov G. P., Arutyunov A. G., Bautin A. E., Boytsov S. A., Koziolova N. A. Guide to the diagnosis and treatment of diseases of the circulatory system in the context pandemic COVID-19. Russian journal of cardiology. 2020;25(3):1–20.
26. Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B., Chadow H. L. ST-segment elevation in patients with Covid-19 — a case series. New England Journal of Medicine. 2020; doi: 10.1056/NEJMc2009020
27. Knight D. S., Kotecha T., Razvi Y., Chacko L., Brown, J.T., Jeetley P. S., Wolff A. COVID-19: Myocardial injury in survivors. Circulation. 2020;142 (11):1120–1122.
28. Golovkin A. S., Kudryavtsev I. V., Dmitriev A. V., Kalinina O. V. Fibrous changes in the cardiovascular and respiratory systems after suffering from COVID-19: the contribution of immune system factors and genetic predisposition. Russian journal of cardiology. 2020;25(10):214–220.
29. Siripanthong B. Nazarian S., Muser D., Deo R., Santangeli P., Khanji M. Y., Chahal C. A. A. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–1471.
30. Xu H., Hou K., Xu H., Li Z., Chen H., Zhang N., Xie L. Acute Myocardial Injury of Patients with Coronavirus Disease 2019. MedRxiv. 2020; https://doi.org/10.1101/2020.04.17.20064691
31. Yancy C. W., Fonarow G. C. Coronavirus disease 2019 (COVID-19) and the heart — Is heart failure the next chapter? JAMA cardiology. 2020;5(11):1216–1217
Review
For citations:
Yaroshchuk N.А., Kochmasheva V.V., Vakhrameev A.V. Cardiac complications in patients with severe COVID-19 pneumonia. Medical alphabet. 2021;(5):14-17. (In Russ.) https://doi.org/10.33667/2078-5631-2021-5-14-17
Views:
511
Email this article 